AzTrials
AzTrials

TourniquetsNCT02465684

Effect of Tourniquet on UKA

A study testing unicondylar knee arthroplasty in people with Tourniquets and Arthroplasty, run by Medical University Innsbruck.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

There is obviously a lack of evidence regarding the risk-benefit ratio of a thigh tourniquet in unicondylar knee arthroplasty (UKA). This refers to many possible outcome criteria like operating time, blood loss, quality of prosthesis fixation in the bone, adverse events, radiographic result, clinical score outcome… Read more about this study

Who is it for?
Ages 18 to 99 years
Conditions the study is for
Tourniquets, Arthroplasty
What is being tested?
unicondylar knee arthroplasty
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
Nov 2016to Jan 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • waiting list for unicondylar knee arthroplasty

Who cannot join

  • failed upper tibial osteotomy,
  • insufficiency of the collateral or anterior cruciate ligaments,
  • a fixed varus or valgus deformity (not passively correctable) above 15°,
  • a flexion deformity greater than 15° and 5) rheumatoid arthritis. In addition - with regard to the scope of the current study - further exclusion criteria will be
  • intake of medicinal anticoagulation prior to surgery
  • liver dysfunction / coagulation dysfunction
  • peripheral arterial obstructive disease.

Trial locations and contacts

No sites are listed yet.

Michael Liebensteiner, Assoc. Prof. contact

+43 512 50480547

michael.liebensteiner@i-med.ac.at

About this study

Official title: The Role of a Thigh Tourniquet in Unicondylar Knee Arthroplasty: a Randomized Controlled Trial

There is obviously a lack of evidence regarding the risk-benefit ratio of a thigh tourniquet in unicondylar knee arthroplasty (UKA). This refers to many possible outcome criteria like operating time, blood loss, quality of prosthesis fixation in the bone, adverse events, radiographic result, clinical score outcome, easy of rehabilitation etc. It is not appropriate to rely on findings from the field of total knee arthroplasty.

It is the aim of the current study, to clarify the role of a thigh tourniquet during UKA with regard to component fixation quality, component positioning and sizing, clinical outcome and rehabilitation process.

Read more

Patients scheduled for routine UKA implantation due to osteoarthritis or osteonecrosis in the medial compartment will be considered for participation.

Patients are then randomized for surgery with or without tourniquet. After an anteromedial Quad-Sparing approach the UKA procedure itself is then carried out, as suggested by the manufacturer. For both groups puls lavage and meticulous drying is applied before cementing.

The following outcome parameters are assessed: 1)radiographic cement mantle thickness, 2)component position \& sizing, 3)diolucencies, 4)score outcome and 5)parameters of early Rehab.

Being tested
unicondylar knee arthroplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • unicondylar knee arthroplastyProcedure or surgery

Study groups in NCT02465684
Study groupRoleWhat they receive
tourniquetExperimentalUKA surgery with tourniquet
Receives: Procedure: unicondylar knee arthroplasty
no tourniquetExperimentalUKA without tourniquet
Receives: Procedure: unicondylar knee arthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. cement mantle thickness

    Measured: 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2015 (estimated)
  2. Study startNov 2016
  3. Primary completionJan 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02465684
Sponsor's protocol ID
UKA-Tourniquet
Status last verified
Jul 2016
First submitted
4 Jun 2015
Last updated
19 Jul 2016
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing unicondylar knee arthroplasty in people with Tourniquets and Arthroplasty, run by Medical University Innsbruck.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 19 Jul 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Michael Liebensteiner, Assoc. Prof. (+43 512 50480547, michael.liebensteiner@i-med.ac.at), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

cement mantle thickness (time frame: 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Jul 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in